Stevanato Group S.p.A. (NYSE:STVN) Shares Sold by Riverbridge Partners LLC

Riverbridge Partners LLC cut its stake in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 5.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 967,030 shares of the company's stock after selling 58,167 shares during the quarter. Riverbridge Partners LLC owned approximately 0.32% of Stevanato Group worth $19,747,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in STVN. Truist Financial Corp grew its holdings in Stevanato Group by 4.2% in the 4th quarter. Truist Financial Corp now owns 26,900 shares of the company's stock worth $586,000 after buying an additional 1,073 shares in the last quarter. New York State Common Retirement Fund acquired a new position in shares of Stevanato Group in the fourth quarter worth $8,879,000. First Bank & Trust increased its stake in shares of Stevanato Group by 7.3% in the fourth quarter. First Bank & Trust now owns 15,145 shares of the company's stock worth $330,000 after acquiring an additional 1,036 shares during the last quarter. Van Berkom & Associates Inc. acquired a new position in Stevanato Group during the fourth quarter worth $39,000. Finally, Oppenheimer Asset Management Inc. increased its position in Stevanato Group by 9.7% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 12,874 shares of the company's stock worth $281,000 after buying an additional 1,141 shares during the last quarter.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on STVN shares. Stephens raised Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. UBS Group reduced their price objective on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a report on Friday, March 7th. Finally, William Blair reissued an "outperform" rating on shares of Stevanato Group in a research note on Friday, March 7th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of €25.70 ($29.54).

Stevanato Group Price Performance

Shares of NYSE STVN opened at €23.68 ($27.22) on Friday. The stock has a market capitalization of $7.17 billion, a price-to-earnings ratio of 46.43, a PEG ratio of 2.27 and a beta of 0.53. The business has a 50-day moving average of €22.74 and a 200-day moving average of €21.72. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.83 and a quick ratio of 1.26. Stevanato Group S.p.A. has a fifty-two week low of €16.56 ($19.03) and a fifty-two week high of €25.75 ($29.60).

Stevanato Group Increases Dividend

The business also recently disclosed an annual dividend, which will be paid on Thursday, July 17th. Stockholders of record on Thursday, June 5th will be issued a $0.0613 dividend. This is a boost from Stevanato Group's previous annual dividend of $0.05. The ex-dividend date of this dividend is Thursday, June 5th. This represents a dividend yield of 0.3%.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.